Silymarin and Hepatitis C: What the Research Shows
Silymarin, an extract from the milk thistle plant, has long been studied for its liver-supportive properties. A laboratory study published in Hepatology (2010;51(6):1912–1921) explored how silymarin affects the hepatitis C virus (HCV).
Researchers infected cultured liver cells with HCV and then treated the cells with either silymarin or standard antiviral therapy. The results were notable:
-
Silymarin blocked viral entry, preventing the hepatitis C virus from getting into healthy liver cells.
-
It disrupted the viral life cycle, interfering with viral RNA and protein production.
-
It prevented cell-to-cell spread, a key mechanism by which HCV persists in the liver.
This was an in vitro (lab-based) study, but it highlights several mechanisms by which silymarin may help protect liver tissue from viral activity.
